Spain· ES:89466
DOLIROBAX 500 MG COMPRIMIDOS
A medicinal product containing metocarbamol, registered in Spain by Faes Farma S.A..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- metocarbamol
- Manufacturer
- Faes Farma S.A.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- June 3, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Metocarbamol in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMethocarbamolMajor Pharmaceuticals
- CzechiaDOLIROBAXGOODWILL PHARMA Plc., Szeged
- FranceLUMIRELAX 500 mg, compriméLABORATOIRES JUVISE PHARMACEUTICALS
- PolandMethocarbamol EspefaChemiczno-Farmaceutyczna Spółdzielnia Pracy ESPEFA
- United KingdomMethocarbamol 1500mg tabletsA A H Pharmaceuticals Ltd
- GermanyMethocaPuren Pharma Gmbh & Co. Kg
- SwitzerlandMetoflex 750 mg, comprimésLabatec Pharma SA
- NorwayMethocarbamol alAliud Pharma
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Methocarbamol Kwizda
- Czechia · Dolirobax
- Germany · Methoca, Methocarbamol Al
- France · Lumirelax, Methocarbamol Arrow
- United Kingdom (Northern Ireland) · Methocarbamol Activase Pharmaceuticals, Methocarbamol Amarox
- Hungary · Dolirobax Tabletta
- Luxembourg · Methocarbamol Micro Labs
- Malta · Rolaxifor
- Poland · Methocarbamol Espefa
- Portugal · Robaxisal, Zelaz
- Slovakia · Dolirobax
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b445e6b2-80ad-403c-b0c9-6b782ed1903d GET /v1/drugs/b445e6b2-80ad-403c-b0c9-6b782ed1903d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1711539050000}",
"nregistro": "89466",
"substance": "metocarbamol"
}See everything about metocarbamol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.